TSW
CVS icon

Thompson Siegel & Walmsley’s CVS Health CVS Stock Holding History

Thompson Siegel & Walmsley’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.1M Sell
78,260
-21,505
-22% -$1.92M 0.15% 162
2026
Q1 		$7.17M Sell
99,765
-33,530
-25% -$2.58M 0.13% 167
2025
Q4 		$10.6M Buy
133,295
+28,006
+27% +$2.21M 0.18% 124
2025
Q3 		$7.94M Sell
105,289
-17,480
-14% -$1.2M 0.13% 161
2025
Q2 		$8.47M Sell
122,769
-7,204
-6% -$472K 0.14% 148
2025
Q1 		$8.81M Buy
129,973
+3,467
+3% +$207K 0.15% 135
2024
Q4 		$5.68M Buy
126,506
+30,520
+32% +$1.71M 0.09% 189
2024
Q3 		$6.04M Sell
95,986
-23,277
-20% -$1.36M 0.09% 180
2024
Q2 		$7.04M Sell
119,263
-1,616
-1% -$101K 0.11% 160
2024
Q1 		$9.64M Sell
120,879
-333
-0.3% -$25.4K 0.15% 137
2023
Q4 		$9.57M Sell
121,212
-38,346
-24% -$2.73M 0.15% 133
2023
Q3 		$11.1M Sell
159,558
-45,962
-22% -$3.26M 0.18% 120
2023
Q2 		$14.2M Sell
205,520
-4,269
-2% -$304K 0.23% 106
2023
Q1 		$15.6M Sell
209,789
-5,852
-3% -$491K 0.25% 98
2022
Q4 		$20.1M Buy
215,641
+24,222
+13% +$2.34M 0.32% 85
2022
Q3 		$18.3M Buy
191,419
+10,356
+6% +$1.03M 0.32% 88
2022
Q2 		$16.8M Sell
181,063
-60,169
-25% -$5.87M 0.27% 99
2022
Q1 		$24.4M Sell
241,232
-106,308
-31% -$11.2M 0.35% 84
2021
Q4 		$35.9M Sell
347,540
-13,031
-4% -$1.2M 0.49% 65
2021
Q3 		$30.6M Buy
360,571
+2,510
+0.7% +$210K 0.44% 71
2021
Q2 		$29.9M Sell
358,061
-16,920
-5% -$1.39M 0.41% 76
2021
Q1 		$28.2M Buy
374,981
+37,413
+11% +$2.73M 0.4% 76
2020
Q4 		$23.1M Buy
337,568
+11,556
+4% +$752K 0.37% 75
2020
Q3 		$19M Buy
326,012
+66,677
+26% +$4.15M 0.37% 77
2020
Q2 		$16.8M Sell
259,335
-2,069
-0.8% -$130K 0.34% 82
2020
Q1 		$15.5M Buy
261,404
+14,423
+6% +$963K 0.37% 80
2019
Q4 		$18.3M Sell
246,981
-173
-0.1% -$12.1K 0.28% 94
2019
Q3 		$15.6M Sell
247,154
-11,029
-4% -$654K 0.25% 97
2019
Q2 		$14.1M Buy
258,183
+24,135
+10% +$1.3M 0.2% 102
2019
Q1 		$12.6M Buy
234,048
+28,705
+14% +$1.77M 0.18% 113
2018
Q4 		$13.5M Buy
205,343
+14,240
+7% +$1.06M 0.21% 110
2018
Q3 		$15M Buy
191,103
+23,210
+14% +$1.66M 0.19% 118
2018
Q2 		$10.8M Buy
167,893
+54,246
+48% +$3.57M 0.14% 137
2018
Q1 		$7.07M Buy
113,647
+5,820
+5% +$418K 0.09% 199
2017
Q4 		$7.82M Sell
107,827
-14,595
-12% -$1.06M 0.09% 198
2017
Q3 		$9.96M Buy
122,422
+17,475
+17% +$1.38M 0.12% 192
2017
Q2 		$8.44M Buy
104,947
+10,158
+11% +$802K 0.1% 201
2017
Q1 		$7.44M Buy
94,789
+59,950
+172% +$4.79M 0.09% 217
2016
Q4 		$2.75M Buy
34,839
+19,410
+126% +$1.57M 0.04% 252
2016
Q3 		$1.37M Sell
15,429
-444
-3% -$41.9K 0.02% 276
2016
Q2 		$1.52M Buy
15,873
+379
+2% +$37.8K 0.02% 252
2016
Q1 		$1.61M Buy
15,494
+200
+1% +$19.4K 0.03% 252
2015
Q4 		$1.5M Sell
15,294
-1,579
-9% -$155K 0.03% 251
2015
Q3 		$1.63M Sell
16,873
-1,486
-8% -$156K 0.03% 258
2015
Q2 		$1.93M Sell
18,359
-1,099
-6% -$112K 0.03% 253
2015
Q1 		$2.01M Sell
19,458
-2,900
-13% -$293K 0.03% 248
2014
Q4 		$2.15M Sell
22,358
-613
-3% -$54K 0.04% 254
2014
Q3 		$1.83M Sell
22,971
-290
-1% -$22.9K 0.04% 251
2014
Q2 		$1.75M Buy
23,261
+10,300
+79% +$778K 0.03% 248
2014
Q1 		$970K Sell
12,961
-5,481
-30% -$387K 0.02% 278
2013
Q4 		$1.32M Sell
18,442
-1,000
-5% -$64.3K 0.03% 269
2013
Q3 		$1.1M Sell
19,442
-13,000
-40% -$775K 0.02% 275
2013
Q2 		$1.85M Buy
+32,442
New +$1.88M 0.04% 274

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Thompson Siegel & Walmsley's CVS Position: Q2 2026 in Review

Thompson Siegel & Walmsley reduced its CVS Health (CVS) stake by 22% in Q2 2026, selling an estimated $1.92M and leaving 78,260 shares worth $8.1M. The position accounts for 0.15% of the portfolio, ranked #162.

Thompson Siegel & Walmsley first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $35.9M in Q4 2021. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Thompson Siegel & Walmsley held 78,260 shares of CVS Health worth $8.1M as of Q2 2026.
  • Thompson Siegel & Walmsley sold 21,505 CVS Health shares in Q2 2026, an estimated $1.92M.
  • CVS Health made up 0.15% of Thompson Siegel & Walmsley's portfolio in Q2 2026, its #162 holding.
  • Thompson Siegel & Walmsley first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • Thompson Siegel & Walmsley's CVS Health position peaked at $35.9M in Q4 2021.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Thompson Siegel & Walmsley's 13F filing for Q2 2026, filed 11 Aug 2026.